Formulation and Evaluation of Linagliptin Nanoparticles Loaded Sublingual Film for Diabetes Mellitus
Year: 2025
Type: article
Abstract: Typically, Diabetes mellitus is a metabolic disorder characterized by the elevation of blood glucose level due to defective or relative deficiency of insulin secretion. This hormone, insulin, is produced by the pancreas. Insulin is like a key that unlocks the door to separate cells from the sugars in our bloodstream. Whereas Type 2 diabetes occurs mainly due to insulin resistance or with relative insulin deficiency The goal is to create Linagliptin SLNs in order to increase the drug's bioavailability and permeability.
Author: Pravin B. Bhoyar, Nitin Padole, Pankaj Dhapke, , Nilakshi Dhoble, Jagdish R. Baheti
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W6893346970
FWCI:
Cites:
Cited by:
Related to: